CAS 1398583-31-7

3-[[[(1R)-1-(4-Fluorophenyl)ethyl](3-quinolinylcarbonyl)amino]methyl]benzoicacid

CAS: 1398583-31-7

Formel: C₂₆H₂₁FN₂O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 428.4549

Ref: IN-DA01ENKI

PF-05105679

CAS: 1398583-31-7

PF-05105679

Reinheit: ≥98%

Molekulargewicht: 428.45g/mol

Ref: 54-BUP12884

PF 05105679

CAS: 1398583-31-7

PF 05105679 is an investigational pharmaceutical compound developed by Pfizer, classified as a selective nicotinic acetylcholine receptor (nAChR) antagonist. It is synthesized through meticulous organic chemistry techniques, representing a targeted approach to modifying neural pathways. The compound functions by selectively inhibiting specific subtypes of nAChRs, which are ligand-gated ion channels integral to synaptic transmission and neurophysiological processes.

Formel: C₂₆H₂₁FN₂O₃

Reinheit: Min. 95%

Molekulargewicht: 428.45 g/mol

Ref: 3D-YFC58331

PF-05105679

CAS: 1398583-31-7

PF-05105679 is a selective TRPM8 antagonist (IC50 = 103 nM). PF-05105679 can be used in research on cold-related pain.

Formel: C₂₆H₂₁FN₂O₃

Reinheit: 99.84%

Farbe und Form: Solid

Molekulargewicht: 428.45

Ref: TM-T16483